271 related articles for article (PubMed ID: 38607056)
1. Mesenchymal-Stem-Cell-Based Therapy against Gliomas.
Santillán-Guaján SM; Shahi MH; Castresana JS
Cells; 2024 Apr; 13(7):. PubMed ID: 38607056
[TBL] [Abstract][Full Text] [Related]
2. Cross talk between mesenchymal and glioblastoma stem cells: Communication beyond controversies.
Bajetto A; Thellung S; Dellacasagrande I; Pagano A; Barbieri F; Florio T
Stem Cells Transl Med; 2020 Nov; 9(11):1310-1330. PubMed ID: 32543030
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells display tumor-specific tropism in an RCAS/Ntv-a glioma model.
Doucette T; Rao G; Yang Y; Gumin J; Shinojima N; Bekele BN; Qiao W; Zhang W; Lang FF
Neoplasia; 2011 Aug; 13(8):716-25. PubMed ID: 21847363
[TBL] [Abstract][Full Text] [Related]
4. In vivo tracking of the tropism of mesenchymal stem cells to malignant gliomas using reporter gene-based MR imaging.
Cao M; Mao J; Duan X; Lu L; Zhang F; Lin B; Chen M; Zheng C; Zhang X; Shen J
Int J Cancer; 2018 Mar; 142(5):1033-1046. PubMed ID: 29047121
[TBL] [Abstract][Full Text] [Related]
5. Suicide gene therapy by canine mesenchymal stem cell transduced with thymidine kinase in a u-87 glioblastoma murine model: Secretory profile and antitumor activity.
Villatoro AJ; Alcoholado C; Martín-Astorga MDC; Rubio N; Blanco J; Garrido CP; Becerra J
PLoS One; 2022; 17(2):e0264001. PubMed ID: 35167620
[TBL] [Abstract][Full Text] [Related]
6. Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas.
Zhang Q; Xiang W; Yi DY; Xue BZ; Wen WW; Abdelmaksoud A; Xiong NX; Jiang XB; Zhao HY; Fu P
Stem Cell Res Ther; 2018 Aug; 9(1):228. PubMed ID: 30143053
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma.
Ahmed AU; Tyler MA; Thaci B; Alexiades NG; Han Y; Ulasov IV; Lesniak MS
Mol Pharm; 2011 Oct; 8(5):1559-72. PubMed ID: 21718006
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells in glioblastoma therapy and progression: How one cell does it all.
Nowak B; Rogujski P; Janowski M; Lukomska B; Andrzejewska A
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188582. PubMed ID: 34144129
[TBL] [Abstract][Full Text] [Related]
9. Tropism of mesenchymal stem cell toward CD133
Pavon LF; Sibov TT; de Souza AV; da Cruz EF; Malheiros SMF; Cabral FR; de Souza JG; Boufleur P; de Oliveira DM; de Toledo SRC; Marti LC; Malheiros JM; Paiva FF; Tannús A; de Oliveira SM; Chudzinski-Tavassi AM; de Paiva Neto MA; Cavalheiro S
Stem Cell Res Ther; 2018 Nov; 9(1):310. PubMed ID: 30413179
[TBL] [Abstract][Full Text] [Related]
10. Exploiting tumor-intrinsic signals to induce mesenchymal stem cell-mediated suicide gene therapy to fight malignant glioma.
Li M; Sun S; Dangelmajer S; Zhang Q; Wang J; Hu F; Dong F; Kahlert UD; Zhu M; Lei T
Stem Cell Res Ther; 2019 Mar; 10(1):88. PubMed ID: 30867058
[TBL] [Abstract][Full Text] [Related]
11. Local Intracerebral Immunomodulation Using Interleukin-Expressing Mesenchymal Stem Cells in Glioblastoma.
Mohme M; Maire CL; Geumann U; Schliffke S; Dührsen L; Fita K; Akyüz N; Binder M; Westphal M; Guenther C; Lamszus K; Hermann FG; Schmidt NO
Clin Cancer Res; 2020 Jun; 26(11):2626-2639. PubMed ID: 31988196
[TBL] [Abstract][Full Text] [Related]
12. Systemic administration of mesenchymal stem cells loaded with a novel oncolytic adenovirus carrying IL-24/endostatin enhances glioma therapy.
Zhang J; Chen H; Chen C; Liu H; He Y; Zhao J; Yang P; Mao Q; Xia H
Cancer Lett; 2021 Jul; 509():26-38. PubMed ID: 33819529
[TBL] [Abstract][Full Text] [Related]
13. Glioma-associated mesenchymal stem cells-mediated PD-L1 expression is attenuated by Ad5-Ki67/IL-15 in GBM treatment.
Zhang Q; Zhang J; Wang P; Zhu G; Jin G; Liu F
Stem Cell Res Ther; 2022 Jun; 13(1):284. PubMed ID: 35765095
[TBL] [Abstract][Full Text] [Related]
14. Ionizing radiation augments glioma tropism of mesenchymal stem cells.
Thomas JG; Parker Kerrigan BC; Hossain A; Gumin J; Shinojima N; Nwajei F; Ezhilarasan R; Love P; Sulman EP; Lang FF
J Neurosurg; 2018 Jan; 128(1):287-295. PubMed ID: 28362237
[TBL] [Abstract][Full Text] [Related]
15. The landscape of the mesenchymal signature in brain tumours.
Behnan J; Finocchiaro G; Hanna G
Brain; 2019 Apr; 142(4):847-866. PubMed ID: 30946477
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells derived from adipose tissue vs bone marrow: in vitro comparison of their tropism towards gliomas.
Pendleton C; Li Q; Chesler DA; Yuan K; Guerrero-Cazares H; Quinones-Hinojosa A
PLoS One; 2013; 8(3):e58198. PubMed ID: 23554877
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas.
Parker Kerrigan BC; Shimizu Y; Andreeff M; Lang FF
Cytotherapy; 2017 Apr; 19(4):445-457. PubMed ID: 28233640
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of glioblastoma cell invasion by hsa-miR-145-5p and hsa-miR-31-5p co-overexpression in human mesenchymal stem cells.
Kurogi R; Nakamizo A; Suzuki SO; Mizoguchi M; Yoshimoto K; Amano T; Amemiya T; Takagishi S; Iihara K
J Neurosurg; 2018 Mar; 130(1):44-55. PubMed ID: 29521593
[TBL] [Abstract][Full Text] [Related]
19. Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy.
Sasportas LS; Kasmieh R; Wakimoto H; Hingtgen S; van de Water JA; Mohapatra G; Figueiredo JL; Martuza RL; Weissleder R; Shah K
Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4822-7. PubMed ID: 19264968
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells loaded with Ad5-Ki67/IL-15 enhance oncolytic adenovirotherapy in experimental glioblastoma.
Wang P; Zhang J; Zhang Q; Liu F
Biomed Pharmacother; 2023 Jan; 157():114035. PubMed ID: 36434955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
